Clinical Study

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study To Assess The Efficacy And Safety Of Oral Bps-314D-Mr Added-On To Treprostinil, Inhaled (Tyvaso®) In Subjects With Pulmonary Arterial Hypertension

Posted Date: May 26, 2017

  • Investigator: Jean Elwing
  • Co-Investigator: Jennifer Daniels
  • Specialties: Lung Disease, Pulmonary Diseases
  • Type of Study: Drug

The purpose of this study is to compare the effect of an oral (by mouth) prostanoid to placebo, when both are used with inhaled Tyvaso. The study will also evaluate the safety of this prostanoid. This study will also keep track of changes in your exercis


You Are Being Asked To Take Part In This Research Study Because You Have Pulmonary Arterial Hypertension (Pah), Which Means That You Have High Blood Pressure In Your Lungs. In Addition, Your Doctors Have Determined That Based On Your Current Pah Conditio


Lung Disease, Pah, Pulmonary, Pulmonary Arterial Hypertension , Shortness Of Breath

For More Information:

Melissa Banuelos
(513) 558-2187

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.